Pablo Villoslada

Dr. Pablo Villoslada, is a neurologist with long term experience in translational medicine, including drug and medical device development. He was Adjunct Professor at the Department of Neurology of the University of California, San Francisco from 2014 to 2017, and worked as Medical Director of Neuroinflammation at Genentech from 2017-2018. Since October 2018 he joined the neurosciences team and became adjunct professor at Stanford University. He has founded several start-ups developing medical devices such as Attune Neurosciences and Health Engineering or drugs for brain diseases Bionure, and is a venture partner with Alta Life Sciences. He has published more than 185 scientific articles and has been granted 13 patents in biomarkers and new therapies for brain diseases. He has also obtained many European and US grants from agencies and international foundations.